Showing 1,281 - 1,300 results of 1,436 for search '"Cancer staging"', query time: 0.22s Refine Results
  1. 1281
  2. 1282

    Body Mass Index and Long-Term Outcomes in Patients With Colorectal Cancer by Faisal Shahjehan, Amit Merchea, Jordan J. Cochuyt, Zhuo Li, Dorin T. Colibaseanu, Pashtoon Murtaza Kasi

    Published 2018-12-01
    “…Multivariable Cox regression models were used to assess the differences in overall survival between BMI groups in each cancer stage, controlling for age, gender, year of diagnosis, and cancer location. …”
    Get full text
    Article
  3. 1283

    Predicting unintentional weight loss in patients with gastrointestinal cancer by Saunjoo L. Yoon, Jung A Kim, Debra Lynch Kelly, Debra Lyon, Thomas J. George Jr.

    Published 2019-06-01
    “…Predictors of weight change were gender (F = 64.93, P < 0.001), cancer stage (F = 7.28, P < 0.001), and site by days (F = 8.24, P < 0.001). …”
    Get full text
    Article
  4. 1284

    The fraction of life years lost after diagnosis (FLYLAD): a person-centred measure of cancer burden by David Banham, Jonathan Karnon, Alex Brown, David Roder, John Lynch

    Published 2023-09-01
    “…FLYLADcancer was estimated for the population of cancer cases diagnosed in South Australia from 1990 to 2010. Cancer stage at diagnosis was also available for cancers diagnosed in Aboriginal people and a cohort of non-Aboriginal people matched by sex, year of birth, primary cancer site and year of diagnosis. …”
    Get full text
    Article
  5. 1285

    Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma by Dongdong Yin, Yinci Zhang, Hui Li, Longqiang Cheng

    Published 2023-12-01
    “…TOP2A and ADH1B expression levels significantly correlated with the patient's gender, age, individual cancer stage, histological subtype, nodal metastasis status, and TP53 mutation status. …”
    Get full text
    Article
  6. 1286

    Extraperitoneal Robotic Laparo-Endoscopic Single-Site Plus1-Port Radical Prostatectomy Using the da Vinci Single-Site Platform by Ching-Chia Li, Tsu-Ming Chien, Ming-Ru Lee, Hsiang-Ying Lee, Hung-Lung Ke, Sheng-Chen Wen, Yii-Her Chou, Wen-Jeng Wu

    Published 2021-04-01
    “…From June 2017 to January 2020, 120 patients with localized prostate cancer (stage T1–T3b) at Kaohsiung Medical University Hospital were included in this study. …”
    Get full text
    Article
  7. 1287

    After accounting for competing causes of death and more advanced stage, do Aboriginal and Torres Strait Islander peoples with cancer still have worse survival? A population-based c... by Hanna E. Tervonen, Richard Walton, Hui You, Deborah Baker, David Roder, David Currow, Sanchia Aranda

    Published 2017-06-01
    “…This cohort study examined whether poorer survival persist after accounting for competing risks of death from other causes and disparities in cancer stage at diagnosis, for all cancers collectively and by cancer site. …”
    Get full text
    Article
  8. 1288

    Analysis of Staged Features of Gastritis-Cancer Transformation and Identification of Potential Biomarkers in Gastric Cancer by Jia R, Guo X, Liu H, Zhao F, Fan Z, Wang M, Sui J, Yin B, Wang Z, Wang Z

    Published 2022-12-01
    “…Additionally, for the gastric cancer stage, the gene expression of the collected tissue transcriptome was validated using the Cancer Genome Atlas and combined with survival analysis to identify potential biomarkers.Results: The 279 overlapping genes among the differentially expressed genes of NAG, AG and CA indicated that the expression characteristics of different stages were different. …”
    Get full text
    Article
  9. 1289

    Suicide risk following a new cancer diagnosis among Veterans in Veterans Health Administration care by Kallisse R. Dent, Benjamin R. Szymanski, Michael J. Kelley, Ira R. Katz, John F. McCarthy

    Published 2023-02-01
    “…The cancer subtype associated with the highest suicide risk was esophageal cancer (aHR = 6.01, 95% CI: 3.73–9.68), and other significant subtypes included head and neck (aHR = 3.55, 95% CI: 2.74–4.62) and lung cancer (aHR = 2.35, 95% CI: 1.85–3.00). Cancer stages 3 (aHR = 2.36, 95% CI: 1.80–3.11) and 4 (aHR = 3.53, 95% CI: 2.81–4.43) at diagnosis were positively associated with suicide risk. …”
    Get full text
    Article
  10. 1290

    Serum Liver‐Type Fatty Acid–Binding Protein Is a Possible Prognostic Factor in Human Chronic Liver Diseases From Chronic Hepatitis to Liver Cirrhosis and Hepatocellular Carcinoma... by Akiko Eguchi, Hiroshi Hasegawa, Motoh Iwasa, Yasuyuki Tamai, Keiichi Ohata, Tsuyoshi Oikawa, Takeshi Sugaya, Yoshiyuki Takei

    Published 2019-06-01
    “…Serum L‐FABP levels were increased in the presence of HCC (P < 0.0001), correlating to des‐gamma‐carboxy prothrombin (P < 0.0001), alpha‐fetoprotein (P = 0.009), and Barcelona‐Clinic Liver Cancer stage. In the average follow‐up period of 1,054 days, serum L‐FABP levels were elevated (P < 0.0001) in patients who eventually died. …”
    Get full text
    Article
  11. 1291

    Economic hardship among principal family caregivers of cancer patients at Khartoum oncology hospital 2020: a cross-sectional study by Ammar Elgadi, Aseel Hisham, Hayat A. Ahmed, Hiba Ali Elzaki, Kamil Merghani Ali shaaban, Ola Dafaalla, Osama Ahmed Elkhidir, Salma S. Alrawa, Tahani Amin Mahmoud, Waad Wadidi

    Published 2022-12-01
    “…There was no significant association between caregiver economic hardship and cancer patient characteristics (patients' age, cancer stage, and treatment type). However, there was a significant association between caregivers' economic hardships and their gender, marital status, educational level, occupation, caregiver monthly gross income, and household monthly gross income. …”
    Get full text
    Article
  12. 1292

    Claudin-18.2 mediated interaction of gastric Cancer cells and Cancer-associated fibroblasts drives tumor progression by Shengde Liu, Zizhen Zhang, Lei Jiang, Miao Zhang, Cheng Zhang, Lin Shen

    Published 2024-01-01
    “…Results In our own cohort, a correlation was observed between high levels of CLDN18.2 expression and advanced cancer stage, poor prognosis, and heightened infiltration of CAFs. …”
    Get full text
    Article
  13. 1293
  14. 1294

    Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort by Alexandre Prieur, Andrew Harper, Momtafin Khan, Bérengère Vire, Dominique Joubert, Léa Payen, Karen Kopciuk

    Published 2023-04-01
    “…In Cox PH regression models adjusted for chemotherapy, radiation therapy, cancer stage and age at diagnosis, log hPG80 (pmol/L) significantly increased the risks for recurrence (Hazard Ratio (HR) = 1.330, 95% Confidence Interval (CI) = (0.995 – 1.777, p = 0.054)), recurrence-free survival (HR = 1.399, 95% CI = (1.106 – 1.770), p = 0.005) and overall survival (HR = 1.385, 95% CI = (1.046 – 1.834), = 0.023) but not for breast cancer specific survival (HR = 1.015, 95% CI = (0.684 – 1.505), p = 0.942). …”
    Get full text
    Article
  15. 1295

    State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan by Yung-Hung Luo, Kung-Hao Liang, Hsu-Ching Huang, Chia-I Shen, Chi-Lu Chiang, Mong-Lien Wang, Shih-Hwa Chiou, Yuh-Min Chen

    Published 2022-06-01
    “…The first subgroup is associated with more advanced cancer stages and visceral pleural invasion, as well as higher mutation burdens. …”
    Get full text
    Article
  16. 1296

    The impact of age on rectal cancer treatment, complications and survival by Øystein Høydahl, Tom-Harald Edna, Athanasios Xanthoulis, Stian Lydersen, Birger Henning Endreseth

    Published 2022-09-01
    “…Results Despite a similar distribution of cancer stages across age-groups, patients aged ≥80 years were treated with a non-curative approach more frequently than younger age groups. …”
    Get full text
    Article
  17. 1297

    Role of Plasma methylated SEPT9 for Predicting Microvascular Invasion and Tumor Proliferation in Hepatocellular Carcinoma by Fei Huang BS, Guowei Yang PhD, Huiqin Jiang MD, Xinning Chen BS, Yihui Yang BS, Qian Yu MD, Baishen Pan PhD, Beili Wang PhD, Wei Guo PhD, Wenjing Yang PhD, Chunyan Zhang MS

    Published 2022-12-01
    “…Pretreatment plasma mSEPT9 was significantly correlated tumor number ( P   =  .004), tumor size ( P   =  4.6  ×  10 −5 ), MVI ( P   =  .002) and Barcelona Clinic Liver Cancer stage ( P   =  .012). Levels of plasma mSEPT9 correlated significantly with Ki67 expression in tumor ( r   =  0.356, P   =  1.3  ×  10 −4 ). …”
    Get full text
    Article
  18. 1298

    Diagnostics Role of Haematological Parameters in Benign and Malignant Breast Lesions: A Retrospective Observational Study from a Tertiary Healthcare Centre in Tamil Nadu, India by Parvesh Anwer, Priyadarshini Kumaraswamy Rajeswaran

    Published 2023-07-01
    “…Aim: This study aimed to evaluate the utility of CBC parameters in diagnosing malignant breast lesions and to analyse the diagnostic role of haematological parameters within benign and malignant breast lesions, as well as different histological breast cancer stages. Materials and Methods: This retrospective observational study was conducted for one year, from January to December 2021, at the Department of Pathology of PSG Institute of Medical Sciences and Research in Coimbatore, Tamil Nadu, India. …”
    Get full text
    Article
  19. 1299

    The Impact of Sarcopenia Onset Prior to Cancer Diagnosis on Cancer Survival: A National Population-Based Cohort Study Using Propensity Score Matching by Chih-Hsiung Su, Wan-Ming Chen, Ming-Chih Chen, Ben-Chang Shia, Szu-Yuan Wu

    Published 2023-03-01
    “…There were no significant differences between the sarcopenia and nonsarcopenia groups in terms of confounding factors such as age (mean 61.05 years versus 62.17 years), gender (52.56% versus 52.16% male, 47.44% versus 47.84% female), comorbidities, and cancer stages. In our multivariate Cox regression analysis, we found that the adjusted hazard ratio (aHR; 95% confidence interval [CI]) of all-cause death for the sarcopenia group compared to the nonsarcopenia group was 1.49 (1.43–1.55; <i>p</i> < 0.001). …”
    Get full text
    Article
  20. 1300

    Disparities in the first-ever diagnosed liver cancers between the emergency department and outpatient department in Taiwan: a population-based study by Tai-Yi Hsu, Jhu-Jing Ye, Sih-Yun Ye, Hsiao-Yuan Tseng, Wen-Yu Chou, Pei-Tseng Kung, Wen-Chen Tsai

    Published 2023-02-01
    “…This study compared the differences in cancer stage and survival between patients who received an initial liver cancer diagnosis in outpatient departments (OPDs) and those who received such a diagnosis in emergency departments (EDs). …”
    Get full text
    Article